Ardelyx, Inc. (ARDX) stock
ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3059% below fair value
$3.09−0.03 (-0.96%)
Close on Nov 13, 2026Market cap $769.99MP/E –Yield –
Ardelyx operating margin
Operating margin is operating income as a percentage of revenue.
Ardelyx's operating margin for the twelve months ending Jun 30, 2026 was -7.9%. For fiscal 2025 it was -10.1%, against -8.4% the year before. The highest annual figure on record is -4.9% in fiscal 2014.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -10.1% | −1.7 |
| FY2024 | Dec 31, 2024 | -8.4% | +42.5 |
| FY2023 | Dec 31, 2023 | -50.8% | +71.4 |
| FY2022 | Dec 31, 2022 | -122.2% | +1406.4 |
| FY2021 | Dec 31, 2021 | -1528.6% | −329.6 |
| FY2020 | Dec 31, 2020 | -1199.0% | +529.1 |
| FY2019 | Dec 31, 2019 | -1728.1% | +1760.4 |
| FY2018 | Dec 31, 2018 | -3488.6% | −3333.5 |
| FY2017 | Dec 31, 2017 | -155.0% | −32.7 |
| FY2015 | Dec 31, 2015 | -122.3% | −117.4 |
| FY2014 | Dec 31, 2014 | -4.9% | +5.0 |
| FY2013 | Dec 31, 2013 | -9.9% | +152.9 |
| FY2012 | Dec 31, 2012 | -162.8% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -10.3% | +4.5 |
| Q1 FY2026 | Mar 31, 2026 | -34.7% | +14.3 |
| Q4 FY2025 | Dec 31, 2025 | 4.1% | −2.9 |
| Q3 FY2025 | Sep 30, 2025 | 4.2% | +2.0 |
| Q2 FY2025 | Jun 30, 2025 | -14.7% | +3.9 |
| Q1 FY2025 | Mar 31, 2025 | -49.0% | +4.6 |
| Q4 FY2024 | Dec 31, 2024 | 7.0% | +88.4 |
| Q3 FY2024 | Sep 30, 2024 | 2.3% | −10.8 |
| Q2 FY2024 | Jun 30, 2024 | -18.6% | +55.8 |
| Q1 FY2024 | Mar 31, 2024 | -53.6% | +175.6 |
| Q4 FY2023 | Dec 31, 2023 | -81.4% | −108.9 |
| Q3 FY2023 | Sep 30, 2023 | 13.1% | +451.9 |
| Q2 FY2023 | Jun 30, 2023 | -74.4% | +963.4 |
| Q1 FY2023 | Mar 31, 2023 | -229.3% | +5712.4 |
| Q4 FY2022 | Dec 31, 2022 | 27.5% | +3455.4 |
| Q3 FY2022 | Sep 30, 2022 | -438.8% | +3161.9 |
| Q2 FY2022 | Jun 30, 2022 | -1037.8% | +2376.7 |
| Q1 FY2022 | Mar 31, 2022 | -5941.7% | −5455.4 |
| Q4 FY2021 | Dec 31, 2021 | -3427.9% | −1899.8 |
| Q3 FY2021 | Sep 30, 2021 | -3600.7% | −2968.1 |
| Q2 FY2021 | Jun 30, 2021 | -3414.5% | −2096.0 |
| Q1 FY2021 | Mar 31, 2021 | -486.3% | +1308.4 |
| Q4 FY2020 | Dec 31, 2020 | -1528.1% | −690.4 |
| Q3 FY2020 | Sep 30, 2020 | -632.5% | +100.6 |
| Q2 FY2020 | Jun 30, 2020 | -1318.5% | +136614.9 |
| Q1 FY2020 | Mar 31, 2020 | -1794.6% | +30412.4 |
| Q4 FY2019 | Dec 31, 2019 | -837.7% | +12960.0 |
| Q3 FY2019 | Sep 30, 2019 | -733.1% | +73113.5 |
| Q2 FY2019 | Jun 30, 2019 | -137933.3% | −137171.0 |
| Q4 FY2018 | Dec 31, 2018 | -32207.1% | −32233.2 |
| Q3 FY2018 | Sep 30, 2018 | -13797.7% | – |
| Q2 FY2018 | Jun 30, 2018 | -73846.7% | – |
| Q1 FY2018 | Mar 31, 2018 | -762.3% | – |
| Q4 FY2017 | Dec 31, 2017 | 26.1% | – |
See a number that looks wrong?